Related Experiment Videos

Experience with amoxycillin in neonates and premature babies

International Journal of Clinical Pharmacology and Biopharmacy
|April 1, 1977
PubMed

Insights

Oral amoxycillin (50 mg/kg) shows effective serum levels in neonates and premature infants. This antibiotic is well-tolerated and recommended for the neonatal and premature period, generally administered every 12 hours.

Area of Science:

  • Pharmacology
  • Neonatal Medicine
  • Pediatric Infectious Diseases

Background:

  • Amoxycillin is a semi-synthetic penicillin with broad-spectrum activity against Gram-positive and Gram-negative organisms.
  • Cross-resistance exists between amoxycillin and ampicillin.

Purpose of the Study:

  • To investigate the pharmacokinetics of oral amoxycillin in neonates and premature infants.
  • To determine appropriate dosing and administration for this population.

Main Methods:

  • Oral administration of amoxycillin at 50 mg/kg body weight.
  • Measurement of serum amoxycillin levels at various time points (peak, 10-hour, 24-hour).
  • Assessment of urinary excretion and meconium levels.

Main Results:

  • Peak serum levels of 38 mcg/ml (neonates) and 59 mcg/ml (premature babies) at 4.25 hours.
  • Detectable serum levels (0.9 mcg/ml) up to 24 hours post-single dose.
  • Urinary excretion averaged 41% over 24 hours.

Conclusions:

  • Amoxycillin is an effective and well-tolerated antibiotic for neonatal and premature infants.
  • Recommended dosage is 50 mg/kg every 12 hours, with 8-hourly administration for severe illnesses.

Related Concept Videos